세계의 정형생물학 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Orthobiologics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2020-2030F
상품코드:1743721
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 189 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 정형생물학 시장은 2024년에는 58억 9,000만 달러로 평가되었고 2030년까지 연평균 성장률(CAGR) 5.10%로 꾸준한 성장이 전망됩니다.
정형생물학은 성장 인자, 줄기세포, 생체재료 등 생물학적 재료의 적용을 통해 뼈, 연골, 인대, 힘줄의 치유와 재생을 촉진하는 의료 분야의 핵심적이고 성장하는 분야입니다. 이러한 생물학적 치료법은 정형외과 수술, 스포츠 의학, 외상 치료 등에서 신체 자체의 자연적 회복 메커니즘을 강화하기 위해 널리 사용됩니다. 바이오기술의 발전은 혈소판 풍부 플라즈마(PRP), 뼈 이식재, 합성 대체재 등 새로운 정형생물학적 솔루션의 개발을 가속화했습니다. AAOS(미국 정형외과 학회)가 수여하는 2025 Arnold I. Caplan Award for Distinguished Research in Orthobiologics와 같은 산업계의 인정은 이 분야에서의 혁신의 중요성을 강조합니다. 최소 침습적 및 재생 치료에 대한 수요가 증가함에 따라 정형생물학적 제제 시장은 지속적인 세계의 성장을 앞두고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
58억 9,000만 달러
시장 규모(2030년)
78억 7,000만 달러
CAGR(2025-2030년)
5.10%
급성장 부문
병원
최대 시장
북미
주요 시장 성장 촉진요인
인구 고령화
주요 시장 과제
장기 데이터 부족
주요 시장 동향
줄기세포 치료
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 정형생물학 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품별(관절내 보충요법 제품, 탈회골 매트릭스, 합성 정형생물학 제품, 골형성 단백질, 동종 이식편 등)
용도별(골관절염 및 퇴행성 관절염, 척추 고정술, 연부 조직 손상 등)
최종 사용자별(병원, 정형외과 클리닉, 외래 진료 센터, 학술연구 기관, 치과 클리닉 및 시설)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024년)
제품 시장 맵
제품별
용도별
최종 사용자별
지역별
제6장 북미의 정형생물학 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 정형생물학 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 정형생물학 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
일본
인도
한국
호주
제9장 남미의 정형생물학 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 정형생물학 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
아랍에미리트(UAE)
사우디아라비아
남아프리카
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 개발
최근 동향
제13장 Porter's Five Forces 분석
제14장 PESTEL 분석
제15장 경쟁 구도
Sanofi SA
Stryker Corporation
Zimmer Biomet
Seaspine Holdings Corporation
Medtronic PLC
DePuy Synthes
Bioventrus
Globus Medical
Arthrex Limited
Orthofix International
제16장 전략적 제안
제17장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global Orthobiologics Market was valued at USD 5.89 billion in 2024 and is projected to grow steadily, registering a CAGR of 5.10% through 2030. Orthobiologics represent a vital and expanding area of the healthcare industry, centered on the application of biological materials-including growth factors, stem cells, and biomaterials-to facilitate the healing and regeneration of bones, cartilage, tendons, and ligaments. These biologically derived treatments are widely used in orthopedic surgery, sports medicine, and trauma care to enhance the body's natural repair mechanisms. Advances in biotechnology have accelerated the development of novel orthobiologic solutions such as platelet-rich plasma (PRP), bone grafts, and synthetic alternatives. Industry recognition, including the 2025 Arnold I. Caplan Award for Distinguished Research in Orthobiologics by AAOS, emphasizes the significance of innovation in this space. As demand rises for minimally invasive and regenerative treatments, the orthobiologics market is positioned for consistent global expansion.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.89 Billion
Market Size 2030
USD 7.87 Billion
CAGR 2025-2030
5.10%
Fastest Growing Segment
Hospitals
Largest Market
North America
Key Market Drivers
Aging Population
The aging global population is a key contributor to the rising demand in the orthobiologics market. With population forecasts by the World Population Prospects 2024 projecting a peak of 10.3 billion by the mid-2080s, the proportion of elderly individuals is set to rise significantly. Aging individuals are increasingly affected by musculoskeletal conditions such as osteoarthritis, joint degeneration, and fractures. These ailments drive demand for less invasive and regenerative treatments, with orthobiologic products like PRP and stem cell therapies emerging as preferred options. Older patients often seek therapeutic solutions that can relieve pain, promote tissue healing, and improve mobility without undergoing major surgery, fueling the market's growth trajectory.
Key Market Challenges
Lack of Long-Term Data
A major limitation in the orthobiologics space is the scarcity of long-term clinical data regarding the safety and efficacy of these treatments. While short-term outcomes have been promising, there is limited evidence on the durability of results, the need for retreatment, and potential long-term complications. This lack of comprehensive follow-up data can cause hesitation among clinicians and patients, slowing widespread adoption. Additionally, the absence of standardized treatment protocols restricts integration into routine clinical practice. Greater investment in long-term studies, post-market surveillance, and real-world evidence is essential to strengthen clinical confidence and support regulatory decision-making.
Key Market Trends
Stem Cell Therapies
Stem cell therapies are gaining traction as a transformative trend in orthobiologics, offering innovative regenerative options for orthopedic care. These therapies utilize either autologous or allogeneic stem cells to restore damaged musculoskeletal tissues. Applications include treatment for osteoarthritis, bone injuries, and cartilage defects. Autologous treatments like bone marrow aspirate concentrate (BMAC) and adipose-derived stem cells capitalize on the body's innate healing ability, while allogeneic options provide ready-to-use therapeutic alternatives. As biotechnology advances, enhanced techniques in cell processing and culture are driving the precision and effectiveness of these treatments. Despite the promise, regulatory challenges and the need for long-term clinical validation remain central to the responsible integration of stem cell-based therapies in mainstream orthopedic care.
Key Market Players
Sanofi SA
Stryker Corporation
Zimmer Biomet
Seaspine Holdings Corporation
Medtronic PLC
DePuy Synthes
Bioventrus
Globus Medical
Arthrex Limited
Orthofix International
Report Scope:
In this report, the Global Orthobiologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Orthobiologics Market, By Product:
Viscosupplementation Products
Demineralized Bone Matrices
Synthetic Orthobiologics
Bone Morphogenic Protein
Allografts
Others
Orthobiologics Market, By Application:
Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Soft-tissue Injuries
Others
Orthobiologics Market, By End User:
Hospitals
Orthopedic Clinics
Ambulatory Care Centers
Academic and Research Institutes
Dental Clinics and Facilities
Orthobiologics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Orthobiologics Market.
Available Customizations:
Global Orthobiologics Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional Market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Orthobiologics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, and Others)
5.2.2. By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, and Others)
5.2.3. By End User (Hospitals, Orthopedic Clinics, and Ambulatory Care Centers, Academic and Research Institutes, and Dental Clinics and Facilities)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. North America Orthobiologics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Orthobiologics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Orthobiologics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Orthobiologics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Orthobiologics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Orthobiologics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. France Orthobiologics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Orthobiologics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Orthobiologics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Orthobiologics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.3. By Product
7.3.5.4. By Application
7.3.5.5. By End User
8. Asia-Pacific Orthobiologics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Orthobiologics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Japan Orthobiologics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. India Orthobiologics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Orthobiologics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Orthobiologics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Orthobiologics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Orthobiologics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Orthobiologics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Orthobiologics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Orthobiologics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Orthobiologics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Orthobiologics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. South Africa Orthobiologics Market Outlook
